UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Patient resources in the therapeutic education of haemophiliacs in France: their skills and roles as defined by consensus of a working group

Haemophilia : the official journal of the World Federation of Hemophilia, 2010-05, Vol.16 (3), p.447-454

2010

Volltextzugriff (PDF)

Analyses of the FranceCoag cohort support differences in immunogenicity among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A

Haematologica (Roma), 2018-01, Vol.103 (1), p.179-189

2018

Volltextzugriff (PDF)

French previously untreated patients with severe hemophilia A after exposure to recombinant factor VIII : incidence of inhibitor and evaluation of immune tolerance

Thrombosis and haemostasis, 1998-11, Vol.80 (5), p.779-783

1998

Volltextzugriff (PDF)

Prophylaxie de longue duree chez les enfants hemophiles a et b severes en prevention de l'arthropathie hemophilique

Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 2009-12, Vol.16 (12), p.1571-1578

2009

Volltextzugriff (PDF)

Acquired inhibitor to factor VIII in a patient with Hodgkin’s disease following treatment with interferon‐alpha

Haemophilia : the official journal of the World Federation of Hemophilia, 2001-09, Vol.7 (5), p.526-527

2001

Volltextzugriff (PDF)

The Kinetics of Antibodies against Hepatitis C Virus May Predict Viral Clearance in Exposed Hemophiliacs

The Journal of infectious diseases, 1998-08, Vol.178 (2), p.556-559

1998

Volltextzugriff (PDF)

Prevalence and significance of hepatitis C virus (HCV) viremia in HCV antibody-positive subjects from various populations

Journal of Clinical Microbiology, 1993-05, Vol.31 (5), p.1189-1193

1993

Volltextzugriff (PDF)

French guidelines. Long-term prophylaxis for severe haemophilia A and B children to prevent haemophiliac arthropathy

Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 2009-12, Vol.16 (12), p.1571-1578

2009

Volltextzugriff (PDF)

Factor VIII recovery after a single infusion of recalibrated ReFacto® in 14 severe haemophilia A patients

Haemophilia : the official journal of the World Federation of Hemophilia, 2007-07, Vol.13 (4), p.357-360

2007

Volltextzugriff (PDF)

Impact of Choice of Treatment for Bleeding Episodes on Inhibitor Outcome in Patients With Mild/Moderate Hemophilia A and Inhibitors

Seminars in hematology, 2006, Vol.43 (1), p.S3-S9

2006

Volltextzugriff (PDF)

Immune tolerance in hemophilia with factor VIII inhibitors: predictors of success

Haematologica (Roma), 2001-11, Vol.86 (11), p.1186

2001

Volltextzugriff (PDF)

INFLUENCE OF THE SOURCE OF PHOSPHOLIPIDS FOR APTT-BASED FIX ASSAYS AND POTENTIAL CONSEQUENCES FOR THE DIAGNOSIS OF MILD/MODERATE HAEMOPHILIA B

Journal of thrombosis and haemostasis, 2007-07, Vol.5, p.P-T-111-P-T-111

2007

Volltextzugriff (PDF)

Infection VIH chez les hémophiles A et B

Revue française de transfusion et d'hémobiologie, 1993-10, Vol.36 (5), p.417-426

1993

Volltextzugriff (PDF)

Detection and IgG subclass analysis of antibodies to factor VIII in multitransfused haemophiliacs and healthy individuals

Haemophilia : the official journal of the World Federation of Hemophilia, 1996-04, Vol.2 (2), p.88-94

1996

Volltextzugriff (PDF)

A new treatment for hemorrhagic complications associated with severe liver disease?

Gastroentérologie clinique et biologique, 1998-06, Vol.22 (6-7), p.652

1998

Volltextzugriff (PDF)

Anti-VHC et receveurs : situation chez les hémophiles en 1991

Revue française de transfusion et d'hémobiologie, 1992-07, Vol.35 (3), p.193-198

1992

Volltextzugriff (PDF)

Incidence of factor VIII inhibitor development in severe hemophilia A patients treated only with one brand of highly purified plasma-derived concentrate

Thrombosis and haemostasis, 1995-02, Vol.73 (2), p.215-218

1995

Volltextzugriff (PDF)

FranceCoag: a 22-year prospective follow-up of the national French cohort of patients with inherited bleeding disorders

European journal of epidemiology, 2019-05, Vol.34 (5), p.521-532

2019

Volltextzugriff (PDF)

Anticorps contre le virus de l'hépatite C chez les hémophiles français

Revue française de transfusion et d'hémobiologie, 1990, Vol.33 (5), p.375-377

1990

Volltextzugriff (PDF)

A cross-over pharmacokinetic study of a double viral inactivated factor IX concentrate (15 nm filtration and SD) compared to a SD factor IX concentrate

Thrombosis and haemostasis, 1998-12, Vol.80 (6), p.919-924

1998

Volltextzugriff (PDF)

PHL11 DEVELOPMENT OF THE HAEMOPHILIA AGEGROUP SPECIFIC QUALITY OF LIFE QUESTIONNAIRE

Value in health, 2003-11, Vol.6 (6), p.744-744

2003

Volltextzugriff (PDF)

Antibodies to hepatitis C virus in haemophilia

The Lancet (British edition), 1989-09, Vol.2 (8662), p.560-561

1989

Volltextzugriff (PDF)

Comparison of anti-human and anti-porcine factor VIII inhibitor levels in 63 patients with severe haemophilia A : a french multicentric study

Vox sanguinis, 1993, Vol.64 (4), p.210-214

1993

Volltextzugriff (PDF)

Hepatitis A in French Hemophiliacs

Vox sanguinis, 1994-01, Vol.67 (Suppl 1), p.9-13

1994

Volltextzugriff (PDF)

Incidence of factor IX inhibitor development in severe haemophilia B patients treated with only one brand of high purity plasma derived factor IX concentrate

Thrombosis and haemostasis, 1999-10, Vol.82 (4), p.1247-1249

1999

Volltextzugriff (PDF)

1 – 25 von 125

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(86)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Patient resources in the therapeutic education of haemophiliacs in France: their skills and roles as defined by consensus of a working group

Analyses of the FranceCoag cohort support differences in immunogenicity among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A

French previously untreated patients with severe hemophilia A after exposure to recombinant factor VIII : incidence of inhibitor and evaluation of immune tolerance

Prophylaxie de longue duree chez les enfants hemophiles a et b severes en prevention de l'arthropathie hemophilique

Acquired inhibitor to factor VIII in a patient with Hodgkin’s disease following treatment with interferon‐alpha

The Kinetics of Antibodies against Hepatitis C Virus May Predict Viral Clearance in Exposed Hemophiliacs

Prevalence and significance of hepatitis C virus (HCV) viremia in HCV antibody-positive subjects from various populations

French guidelines. Long-term prophylaxis for severe haemophilia A and B children to prevent haemophiliac arthropathy

Factor VIII recovery after a single infusion of recalibrated ReFacto® in 14 severe haemophilia A patients

Impact of Choice of Treatment for Bleeding Episodes on Inhibitor Outcome in Patients With Mild/Moderate Hemophilia A and Inhibitors

Immune tolerance in hemophilia with factor VIII inhibitors: predictors of success

INFLUENCE OF THE SOURCE OF PHOSPHOLIPIDS FOR APTT-BASED FIX ASSAYS AND POTENTIAL CONSEQUENCES FOR THE DIAGNOSIS OF MILD/MODERATE HAEMOPHILIA B

Infection VIH chez les hémophiles A et B

Detection and IgG subclass analysis of antibodies to factor VIII in multitransfused haemophiliacs and healthy individuals

A new treatment for hemorrhagic complications associated with severe liver disease?

Anti-VHC et receveurs : situation chez les hémophiles en 1991

Incidence of factor VIII inhibitor development in severe hemophilia A patients treated only with one brand of highly purified plasma-derived concentrate

FranceCoag: a 22-year prospective follow-up of the national French cohort of patients with inherited bleeding disorders

Anticorps contre le virus de l'hépatite C chez les hémophiles français

A cross-over pharmacokinetic study of a double viral inactivated factor IX concentrate (15 nm filtration and SD) compared to a SD factor IX concentrate

PHL11 DEVELOPMENT OF THE HAEMOPHILIA AGEGROUP SPECIFIC QUALITY OF LIFE QUESTIONNAIRE

Antibodies to hepatitis C virus in haemophilia

Comparison of anti-human and anti-porcine factor VIII inhibitor levels in 63 patients with severe haemophilia A : a french multicentric study

Hepatitis A in French Hemophiliacs

Incidence of factor IX inhibitor development in severe haemophilia B patients treated with only one brand of high purity plasma derived factor IX concentrate

Suchergebnisse filtern